16.20
0.31 (1.95%)
| Penutupan Terdahulu | 15.89 |
| Buka | 15.99 |
| Jumlah Dagangan | 197,124 |
| Purata Dagangan (3B) | 514,046 |
| Modal Pasaran | 5,737,874,944 |
| Harga / Pendapatan (P/E Ke hadapan) | 15.27 |
| Harga / Jualan (P/S) | 1.10 |
| Harga / Buku (P/B) | 0.850 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | -7.50% |
| Margin Operasi (TTM) | -5.36% |
| EPS Cair (TTM) | -1.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 75.07% |
| Nisbah Semasa (MRQ) | 1.56 |
| Aliran Tunai Operasi (OCF TTM) | 166.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 69.00 M |
| Pulangan Atas Aset (ROA TTM) | 0.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Bausch + Lomb Corporation | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.88 |
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 88.13% |
| % Dimiliki oleh Institusi | 10.97% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 21.00 (Morgan Stanley, 29.63%) | Beli |
| Median | 17.00 (4.94%) | |
| Rendah | 16.00 (Goldman Sachs, -1.24%) | Pegang |
| 16.00 (JP Morgan, -1.24%) | Pegang | |
| Purata | 17.78 (9.75%) | |
| Jumlah | 5 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 15.36 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 02 Dec 2025 | 21.00 (29.63%) | Beli | 17.05 |
| RBC Capital | 14 Nov 2025 | 19.00 (17.28%) | Beli | 15.60 |
| Wells Fargo | 14 Nov 2025 | 17.00 (4.94%) | Pegang | 15.60 |
| 30 Oct 2025 | 16.00 (-1.23%) | Pegang | 15.14 | |
| Barclays | 31 Oct 2025 | 17.00 (4.94%) | Pegang | 14.94 |
| HC Wainwright & Co. | 31 Oct 2025 | 17.00 (4.94%) | Beli | 14.94 |
| Evercore ISI Group | 30 Oct 2025 | 18.00 (11.11%) | Beli | 15.14 |
| 07 Oct 2025 | 17.00 (4.94%) | Beli | 14.66 | |
| JP Morgan | 30 Oct 2025 | 16.00 (-1.23%) | Pegang | 15.14 |
| Raymond James | 30 Oct 2025 | 19.00 (17.28%) | Beli | 15.14 |
| Goldman Sachs | 01 Oct 2025 | 16.00 (-1.23%) | Pegang | 14.67 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |